Grove Collaborative Holdings (GROV) Acquires 8Greens

Grove Collaborative Holdings, Inc. (NYSE: GROV) today announced it has completed the purchase of substantially all of the assets of 8Greens, an early natural wellness company and one of the first brands to create daily greens supplements in gummy and effervescent tablet formats. This acquisition provides a strong foothold for Grove to continue its expansion into wellness, support customers’ needs for quality supplements, and partner with a beloved brand to educate on human health.

“8Greens and its industry leadership in wellness — vitamins, minerals, and supplements — has helped to drive consumer adoption of greens products that are now present in daily routines, leading with science, education, and quality to improve health outcomes for its customers,” said Jeff Yurcisin, CEO of Grove Collaborative. “As a retailer, we at Grove are dedicated to being THE destination for conscientious consumers who want the best for themselves, their families, and the planet. This acquisition expands our owned brand product offering and helps us better educate the Grove customer to serve their needs.”

8Greens is well known for their supplements that help customers get a significant dose of eight essential greens packed with vital nutrients — spinach, kale, aloe vera, wheatgrass, blue green algae, barley grass, chlorella, and spirulina. Ninety percent of Americans don’t get their daily recommended amount of vegetables1 — one cup per day — and 8Greens set out to make it easier for people to eat more greens. 8Greens’ mission and values are well aligned with Grove while complementing the retailer’s existing portfolio of vitamins, minerals, and supplements. 8Greens was founded in 2015 by Dawn Russell with her husband, Jamie Russell, after a cancer diagnosis led her to overhaul her diet. She credits the power of greens as a key part of her own health journey and recovery, inspiring her to partner with Dr. Paula Trumbo, nutrition scientist and former Nutrition Science Review Team lead at the Food & Drug Administration, to create supplement prototypes over the course of five years. Their supplement products come in powders, tablets, gummies, and lollipops that support a range of key wellness focus areas, including metabolism, gut health, immunity, brain focus, and skin health.

"I'm thrilled for 8Greens to join forces with Grove Collaborative, a company that shares our goal of helping busy, hard-working people and families get health and wellness education and products from one trusted destination," said Dawn Russell, founder of 8Greens. "With millions of 8Greens supplements as part of people’s daily routines since 2015, this acquisition by Grove allows us to expand our platform to even more families. We’re excited for Grove to provide the same products, same formulas, and same taste through better, faster delivery and customer service to help Americans be healthier.”

“At 8Greens, we’ve always been committed to creating science-backed, nutrient-rich solutions that help people easily incorporate essential greens into their daily lives," said Dr. Paula Trumbo, Nutrition Scientist at 8Greens. "Being part of Grove Collaborative strengthens 8Greens’ ability to educate consumers on the critical connection between nutrition and overall wellness, ensuring more people have access to high-quality supplements that support their health in a meaningful way.”

Dawn Russell will always be the 8 Greens Founder, but will now join Grove as a consultant, where she’ll work across teams to help develop educational content focused on wellness and human health while also supporting integration and ongoing product development. 8 Greens products will be sold online through Grove Collaborative’s marketplace starting in April 2025 in addition to existing platforms including the 8Greens site, Amazon, and QVC. The products will be available online only in the lower 48 United States.

For more information, visit www.grove.co.

You May Also Be Interested In

• Apple revises EU app distribution terms, cuts fees and expands access
• Infleqtion opens new Colorado headquarters for quantum work
• BioMarin to acquire Alesta Therapeutics for $275M upfront